"Trovex" in the Treatment of Microsporia

Alexander Katsitadze, Nathalie Kiladze, Zurab Bendeliani, Nino Tsiskarishvili, Gaioz Pagava

The goal of present study was to evaluate the therapeutic efficiency of Georgian produced drug "Trovex" (terbinafine) manufactured by Pharmimpex LTD, in the treatment of Microsporia. The study included 10 patients in the age of 5- 10 years old with Microsporia of scalp and smooth skin, all infected from pets. In all cases the diagnosis was confirmed by direct microscopy of scrapings and with the use of Wood's light. All patients were treated by "Trovex" orally with the dose of 125 mg once a day. The course of treatment varied from 4 up to 6 weeks in accordance with the sites of involvement - body or scalp lesions. The regimen was well tolerated by all patients and all of them showed complete clinical recovery. After the end of treatment only 2 patients while screening with Wood's lamp had weak fluorescence at the ends of the newly grown hair, which intensity progressively decreased within one week. "Trovex" was proved to be highly effective and safe antimycotic preparation for treatment of Microsporia in children.

Keywords:  Trovex, microsporia